Navigation Links
Hill-Rom® P500 Therapy Surface Introduced for Use With Most Flat Deck Bed Systems
Date:9/30/2010

BATESVILLE, Ind., Sept. 30 /PRNewswire/ -- Hill-Rom (NYSE: HRC) today announced the introduction of the Hill-Rom® P500 Therapy Surface with sophisticated treatment features and added versatility, now making it compatible with most flat deck bed systems.

"Our customers have been very pleased with our P500 Therapy Surfaces that were recently introduced with custom design for our VersaCare® and our TotalCare® bed systems," said Mary Butler, vice president, Global Product Management for Hill-Rom. "These surfaces really resonate with our customers because they are easy to use and they provide key safety features to help caregivers effectively treat their patients. Now we are introducing the Hill-Rom P500 system with even more versatility as it can be paired with most flat deck beds. That makes this surface a perfect option for purchase with new beds, as a replacement surface for existing beds or as a therapy surface that can be rented."

She added, "Caregivers are really looking for a therapy surface to help keep their patients safe and to prevent or help heal skin issues like pressure ulcers. This surface brings together state-of-the-art technology that accomplishes that goal, while still being easy to use and comfortable for the patient."

The Hill-Rom P500 Therapy Surface offers a mix of key features, including:

  • Weight-based pressure redistribution supporting patients up to 500 pounds
  • Advanced Microclimate® Technology, which is the most advanced low air loss system available
  • Turn Assist with "confirm rails up" feature to aid the caregiver in turning the patient left or right
  • Audible and visual Bed Exit, 30-degree Head-of-Bed and RemindMe™ alarms to help reduce the risk of caregiver and patient injury
  • Shear-resistant material and a real-time pressure redistribution a
    '/>"/>

SOURCE Hill-Rom
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Tengion Presents New Data Demonstrating Functional Regeneration in a Diabetic Chronic Kidney Failure Model at the International Society for Cellular Therapy
2. Boston Scientific Welcomes Publication of Analysis Demonstrating Long-Term Survival Benefit for ICD Therapy
3. New Laboratory Data Analyzes Physical Performance Characteristics of Unique Bio-Dome™ and GranuFoam™ Negative Pressure Wound Therapy Dressings
4. Results From Argos Therapeutics Arcelis™ Immunotherapy Phase 2 Study for Treatment of Renal Cell Carcinoma (RCC) Accepted for Poster Presentation at Ninth International Kidney Cancer Symposium
5. Promising New Therapy for Drug-Resistant Hypertension Presented at Interventional Cardiology Meeting in Washington, D.C.
6. NeoStem and Progenitor Cell Therapy Announce Entry Into Merger Agreement
7. Novartis Drug SOM230 is First Medical Therapy to Show Efficacy in a Phase III Trial in Cushings Disease, a Debilitating Hormonal Disorder
8. Facelift Healing Innovation: New Study Shows Hyperbaric Oxygen Therapy Decreases Bruising in Facelifts Patients by 35%
9. Data From Landmark Study Evaluating Gender Differences in Response to an HIV Therapy Published in Annals of Internal Medicine
10. Adding Lantus® to Oral Antidiabetic Drug Therapy Further Reduced Blood Sugar in Patients with Type 2 Diabetes
11. Xoft Introduces Electronic Brachytherapy Cancer Treatment Platform at ESTRO Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... July 11, 2014  Australian drug delivery company, Phosphagenics ... has raised A$19.3 million via a placement of A$16.3 ... , the U.S., Asia and ... a share purchase plan (SPP) to be offered to ... made in two tranches. "This capital raising ...
(Date:7/11/2014)... , July 11, 2014  Veran Medical ... announced today the positive, cost-effective final results ... SPiNPerc™ procedure. The SPiNPerc endobronchial percutaneous biopsy ... percutaneous approach to biopsy when a traditional ... and physicians experience positive financial outcomes when ...
(Date:7/10/2014)... , 11. Juli 2014 /PRNewswire/ ... Kameras für die molekulare Bildgebung, einschließlich ... heute die CE-Zulassung für sein Navigator ... kann Dilon das Produkt jetzt europaweit ... den Großteil der europäischen Länder ausgedehnt ...
Breaking Medicine Technology:Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3Veran Medical Publishes Lung Cancer Patient Management Study 2Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2
... , , MOUNTAIN VIEW, Calif. ... announced the initiation of a Phase I clinical trial ... autoimmune diseases.  CCX168 is a highly potent and very ... a component of the body,s complement system and a ...
... , Jan. 28 , Net Sales of $1.11 ... period (an increase of 2.5% constant currency) , Diluted ... from the prior year period, and $1.12 adjusted, an increase of 12.0% ... of $4.10 billion for the full year represent a decrease of 0.6% ...
Cached Medicine Technology:ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases 2ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases 3ChemoCentryx Initiates Clinical Trial of CCX168, A Novel Small Molecule C5aR Antagonist for the Treatment of Inflammatory and Autoimmune Diseases 4Zimmer Reports Fourth Quarter and 2009 Financial Results 2Zimmer Reports Fourth Quarter and 2009 Financial Results 3Zimmer Reports Fourth Quarter and 2009 Financial Results 4Zimmer Reports Fourth Quarter and 2009 Financial Results 5Zimmer Reports Fourth Quarter and 2009 Financial Results 6Zimmer Reports Fourth Quarter and 2009 Financial Results 7Zimmer Reports Fourth Quarter and 2009 Financial Results 8Zimmer Reports Fourth Quarter and 2009 Financial Results 9Zimmer Reports Fourth Quarter and 2009 Financial Results 10Zimmer Reports Fourth Quarter and 2009 Financial Results 11Zimmer Reports Fourth Quarter and 2009 Financial Results 12Zimmer Reports Fourth Quarter and 2009 Financial Results 13Zimmer Reports Fourth Quarter and 2009 Financial Results 14Zimmer Reports Fourth Quarter and 2009 Financial Results 15Zimmer Reports Fourth Quarter and 2009 Financial Results 16Zimmer Reports Fourth Quarter and 2009 Financial Results 17Zimmer Reports Fourth Quarter and 2009 Financial Results 18Zimmer Reports Fourth Quarter and 2009 Financial Results 19Zimmer Reports Fourth Quarter and 2009 Financial Results 20Zimmer Reports Fourth Quarter and 2009 Financial Results 21Zimmer Reports Fourth Quarter and 2009 Financial Results 22Zimmer Reports Fourth Quarter and 2009 Financial Results 23Zimmer Reports Fourth Quarter and 2009 Financial Results 24Zimmer Reports Fourth Quarter and 2009 Financial Results 25Zimmer Reports Fourth Quarter and 2009 Financial Results 26Zimmer Reports Fourth Quarter and 2009 Financial Results 27
(Date:7/13/2014)... (PRWEB) July 13, 2014 Recently, ... retailer, has unveiled its new range of gorgeous ... current market, the demand for elegant Quinceanera outfits ... more beautiful items. All the company’s newly released ... trends. They are all elegant and vivid. ...
(Date:7/13/2014)... 13, 2014 Fadhits.com is popular among ... dresses are extremely beautiful. Recently, the company has announced ... for 2014. What’s more, all these outfits are available ... , Additionally, the supplier is now offering similar ... Quinceanera dresses, it has many other designs for sale, ...
(Date:7/13/2014)... A decreased ability to identify odors might ... disease, while examinations of the eye could indicate ... Alzheimer,s, in the brain, according to the results ... Alzheimer,s Association International Conference 2014 (AAIC 2014) in ... decreased ability to identify odors was significantly associated ...
(Date:7/13/2014)... 13, 2014 A Xarelto lawsuit ... LLC to provide consumers with the most current information ... of the blood-thinning medication, as well as the ... courts around the country. The law firm is now ... suffered from life-threatening internal bleeding and related complications while ...
(Date:7/13/2014)... Hope Palliative & Hospice Care announced today ... at the Tamarack Senior Living Community in Palatine, IL. The ... on the 3rd Wednesdays of every month. This group ... Community located at 55 S. Greeley St. Palatine, IL 60067. ... is no cost for the group. , “A grief ...
Breaking Medicine News(10 mins):Health News:2014QuinceaneraDresses.com Releases Its New Quinceanera Dresses 2Health News:Fadhits.com Announces a Special Offer on Elegant Quinceanera Dresses 2Health News:Smell and eye tests show potential to detect Alzheimer's early 2Health News:Smell and eye tests show potential to detect Alzheimer's early 3Health News:Smell and eye tests show potential to detect Alzheimer's early 4Health News:Smell and eye tests show potential to detect Alzheimer's early 5Health News:Smell and eye tests show potential to detect Alzheimer's early 6Health News:Smell and eye tests show potential to detect Alzheimer's early 7Health News:Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation 2Health News:Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation 3Health News:Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation 4Health News:Hope Hospice Announces Grief Support Group at the Tamarack Senior Living Community 2
... Systems (TSX: LMZ,AMEX: LMZ), a healthcare technology company ... for obstetrics, today announced that its,Board of Directors ... from Amex., The decision is in keeping ... control costs in order to become cash flow,positive. ...
... Presentations highlight Palomid 529 as an inhibitor of macular ... ... JAMAICA PLAIN, Mass., May 1 Paloma Pharmaceuticals,Inc. today announced ... the Association for Research in Vision and Ophthalmology (ARVO),describing the ...
... The Cosmetic Bootcamp LLC,announced today that its summer ... According to Dr. Kenneth Beer, this year,s meeting is,expected ... meeting has,experienced since its inception four years ago. Dr. ... credibility the meeting has gained with both,physicians and industry. ...
... 1 Perrigo Company,(Nasdaq: PRGO ; TASE) ... a,quarterly dividend of $0.05 per share, payable on ... 25, 2008., Perrigo Company is a leading ... (OTC) and prescription,pharmaceuticals, nutritional products, active pharmaceutical ingredients,(API) ...
... MedCath Corporation,(Nasdaq: MDTH ) announced that its ... Securities 33rd Annual Health Care,Conference held May 5 - ... management will give its presentation on Wednesday,May 7 at ... live over the,Internet via MedCath,s website ( http://www.medcath.com ) ...
... increases 5 percent to $22.9 billion, - GAAP earnings from continuing operations reach $366 million from ... of $5 million in the prior-year period, - GAAP diluted earnings per share from ... from a loss of $0.01 in prior-year period, - Non-GAAP diluted EPS from ... ...
Cached Medicine News:Health News:LMS to delist from Amex 2Health News:Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology Meeting 2Health News:Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology Meeting 3Health News:Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology Meeting 4Health News:Cardinal Health Reports Third Quarter Results 2Health News:Cardinal Health Reports Third Quarter Results 3Health News:Cardinal Health Reports Third Quarter Results 4Health News:Cardinal Health Reports Third Quarter Results 5Health News:Cardinal Health Reports Third Quarter Results 6Health News:Cardinal Health Reports Third Quarter Results 7Health News:Cardinal Health Reports Third Quarter Results 8Health News:Cardinal Health Reports Third Quarter Results 9Health News:Cardinal Health Reports Third Quarter Results 10Health News:Cardinal Health Reports Third Quarter Results 11Health News:Cardinal Health Reports Third Quarter Results 12Health News:Cardinal Health Reports Third Quarter Results 13Health News:Cardinal Health Reports Third Quarter Results 14Health News:Cardinal Health Reports Third Quarter Results 15Health News:Cardinal Health Reports Third Quarter Results 16Health News:Cardinal Health Reports Third Quarter Results 17Health News:Cardinal Health Reports Third Quarter Results 18Health News:Cardinal Health Reports Third Quarter Results 19Health News:Cardinal Health Reports Third Quarter Results 20Health News:Cardinal Health Reports Third Quarter Results 21Health News:Cardinal Health Reports Third Quarter Results 22Health News:Cardinal Health Reports Third Quarter Results 23Health News:Cardinal Health Reports Third Quarter Results 24Health News:Cardinal Health Reports Third Quarter Results 25Health News:Cardinal Health Reports Third Quarter Results 26Health News:Cardinal Health Reports Third Quarter Results 27Health News:Cardinal Health Reports Third Quarter Results 28Health News:Cardinal Health Reports Third Quarter Results 29Health News:Cardinal Health Reports Third Quarter Results 30Health News:Cardinal Health Reports Third Quarter Results 31
VascoTwist is a low profile unipolar permanent pacing lead with a retractable screw. Due to advanced technology VascoTwist 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
Medicine Products: